Top of pageA
ACIR
See: Childhood immunisation coverage
Acquired immunodeficiency disease syndrome
See HIV and AIDS
Acute flaccid paralysis
See: Poliomyelitis
Adverse events following immunisation
annual report, 2006; 269–282
supplementary report: 1 January to 30 June 2007; 379–382
AIDS
See: HIV and AIDS
Annual report
See: Individual surveillance programs
Anthrax
See: Communicable diseases surveillance: tables
Antimicrobial resistance
prevalence of antimicrobial resistance in Enterococcus isolates in Australia, 2005; 392–397
prevalence of antimicrobial resistances in common pathogenic Enterobacteriaceae in Australia, 2004: report from the Australian Group on Antimicrobial Resistance; 106–112
prevalence of MRSA among Staphylococcus aureus isolated from hospital inpatients, 2005: Report from the Australian Group for Antimicrobial Resistance; 288–296
Arbovirus infection
See: Barmah Forest virus infection; Japanese encephalitis virus; Kunjin virus infection; malaria; Murray Valley encephalitis virus
ASPREN
See: Australian Sentinel Practice Research Network
AusReady
new facility to help fight emerging infectious diseases; 343
Australia’s notifiable diseases status, 2005: annual report of the National Notifiable Diseases Surveillance System; 1–70
Australian bat lyssavirus
See: Rabies
Australian Childhood Immunisation Register
See: Childhood immunisation coverage
Australian encephalitis
See: National Arbovirus and Malaria Advisory Committee
Australian Gonococcal Surveillance Programme
annual report, 2006; 180–184
quarterly surveillance report; 149–151, 439–440
surveillance data in CDI explanation; 162
See also: Gonococcal infection
Australian Meningococcal Surveillance Programme
quarterly surveillance report; 162, 254, 336, 441
See also: Meningococcal infection
Australian Mycobacterium Reference Laboratory Network
See: Tuberculosis
Australian National Creutzfeldt-Jakob Disease Registry
See: Creutzfeldt-Jakob disease
Australian National Poliovirus Reference Laboratory
See: Poliomyelitis
Australian Paediatric Surveillance Unit
surveillance data in CDI explanation; 163
Australian Rotavirus Surveillance Program
annual report, 2006–07; 375–379
See also: Rotavirus
Australian Sentinel P+ractice Research Network
quarterly surveillance report; 147, 330–331, 436–437
surveillance data in CDI explanation; 160–161
Avian influenza
overseas brief; 154, 257, 339, 445
See also: Influenza
Top of pageB
Barmah Forest virus infection
See: Communicable diseases surveillance: tables
BCG
See: Tuberculosis
Bird flu
See: Avian influenza
Bloodborne diseases
See: Communicable diseases surveillance: tables;
See also: Hepatitis B; hepatitis C; hepatitis D; HIV and AIDS
Botulism
See: Communicable diseases surveillance: tables
Bovine spongiform encephalopathy
See: Creutzfeldt-Jakob disease
Brucellosis
See: Communicable diseases surveillance: tables
Top of pageC
Campylobacter
See: Campylobacteriosis
Campylobacteriosis
See: Communicable diseases surveillance: tables
Chickenpox
See: Varicella
Chikungunya
overseas brief; 154, 257, 444
Childhood immunisation coverage
how reliable are Australian Childhood Immunisation Register coverage estimates for Indigenous children? An assessment of data quality and coverage; 283–287
quarterly surveillance report; 147–149, 251–252, 333–334, 437–439
surveillance data in CDI explanation; 163–164
Chlamydia
See: Chlamydial infection
Chlamydial infection
See: Communicable diseases surveillance: tables
Cholera
overseas brief; 154–155, 257, 444
See also: Communicable diseases surveillance: tables
Communicable Diseases Intelligence
change of contact details; 447
errata; 164–165, 262, 448
instructions for authors; 157–159
letter to the Editor; 419
surveillance systems reported in, 2007; 159–164
Communicable diseases surveillance
highlights for 4th quarter, 2006; 134–137
highlights for 1st quarter, 2007; 240–241
highlights for 2nd quarter, 2007; 319–320
highlights for 3rd quarter, 2007; 425–426
surveillance systems reported in, 2007; 159–164
tables; 138–146, 242–264, 321–329, 427–435
See also: Individual diseases
Compliance with three simultaneous vaccinations due at the one visit at 12 months of age in Australia; 198–202
Composition of the Australian Influenza Vaccine for the 2007 season; 260
Creutzfeldt-Jakob disease: Australian surveillance update to March 2007; 194–197
Cryptosporidiosis
See: Communicable diseases surveillance: tables
Top of pageD
Dengue
overseas brief; 155, 257, 339–340, 444–445
See also: Communicable diseases surveillance: tables
Dengue haemorrhagic fever
overseas brief; 155
Diphtheria
See: Communicable diseases surveillance: tables
Top of pageE
Ebola haemorrhagic fever
overseas brief; 445
Emerging infectious diseases
AusReady: new facility to help fight emerging infectious diseases; 343
Encephalitis: Australian
See: National Arbovirus and Malaria Advisory Committee
Enterococcus
prevalence of antimicrobial resistance in Enterococcus isolates in Australia, 2005; 392–397
Enteroviruses
See: Poliomyelitis
Escherichia coli
See: Shiga-like toxin producing Escherichia coli/verotoxin producing E. coli
Haemolytic uraemic syndrome associated with a family cluster of enterohaemorrhagic Escherichia coli; 300–303
Exercise Paton: A simulation exercise to test New South Wales emergency departments’ response to pandemic influenza; 310–313
Top of pageF
Flavivirus
See: Sentinel Chicken Surveillance Program
See also: Dengue; Japanese encephalitis virus; Kunjin virus infection; Murray Valley encephalitis virus
Foodborne disease
See: OzFoodNet;
See also: Communicable diseases surveillance: tables; salmonellosis
Top of pageG
Gastroenteritis
See: Gastrointestinal diseases
Gastrointestinal diseases
See: Botulism; campylobacteriosis; Communicable diseases surveillance: tables; cryptosporidiosis; haemolytic uraemic syndrome; hepatitis A; hepatitis E; listeriosis; salmonellosis; Shiga-like toxin producing Escherichia coli/verotoxin producing E. coli; typhoid
Gonococcal infection
Communicable diseases surveillance: tables quarterly surveillance report; 331–332, 439–440
See also: Communicable diseases surveillance: tables
Gonorrhoea
See: Gonococcal infection
Top of pageH
Haemolytic uraemic syndrome
associated with a family cluster of enterohaemorrhagic Escherichia coli; 300–303
See also: Communicable diseases surveillance: tables
Haemophilus influenzae type b
See: Communicable diseases surveillance: tables
Haemorrhagic fever
See: Viral haemorrhagic fever
Hepatitis A
See: Communicable diseases surveillance: tables
Hepatitis B
See: Communicable diseases surveillance: tables
Hepatitis C
See: Communicable diseases surveillance: tables
Hepatitis D
See: Communicable diseases surveillance: tables
Hepatitis E
See: Communicable diseases surveillance: tables
HIV
See Human immunodeficiency virus
HIV and AIDS
quarterly surveillance reports; 153–154, 253, 334
surveillance data in CDI explanation; 161
Human immunodeficiency virus
overseas brief; 257–258
Human pituary hormone
See: Creutzfeldt-Jakob disease
Top of pageI
Immunisation
See: vaccination
See also: Childhood immunisation coverage
Importation of wild poliovirus into Australia, July 2007; 299
Influenza
ASPREN data
See: Australian Sentinel Practice Research Network
Exercise Paton: A simulation exercise to test New South Wales emergency departments’ response to pandemic influenza; 310–313
observations on managing an outbreak of influenza A infection in an aged care facility; 410–412
pneumonia cluster in a boarding school – implications for influenza control; 296–298
surveillance in Victoria, annual report 2006; 100–106
surveillance within hospitals: what is the world doing?; 413–418
See also: Communicable diseases surveillance: tables, National Influenza Surveillance Scheme
Interferon-γ release immunoassays in the detection of latent tuberculosis infection, NTAC position paper, October 2007; 404–405
Invasive meningococcal infections
See: Meningococcal infection
See also: Communicable diseases surveillance: tables;
Invasive pneumococcal disease
See: Pneumococcal disease
See also: Communicable diseases surveillance: tables;
Invasive pneumococcal disease in Australia
annual report 2005; 86–100
Top of pageJ
Japanese encephalitis virus
See: Communicable diseases surveillance: tables
Top of pageK
Kunjin virus infection
See: Communicable diseases surveillance: tables
Top of pageL
Laboratory Virology and Serology Reporting Scheme
surveillance data in CDI explanation; 162–163
tables; 144–146, 327–329, 433–435
LabVISE
See: Laboratory Virology and Serology Reporting Scheme
Legionellosis
See: Communicable diseases surveillance: tables
Leprosy
See: Communicable diseases surveillance: tables
Leptospirosis
Epidemiology of Leptospira weilii serovar Topaz infections in Australia; 216–222
See also: Communicable diseases surveillance: tables
Listeriosis
See: Communicable diseases surveillance: tables
Lyssavirus
See: Rabies
Top of pageM
Malaria
overseas brief; 155
See also: Communicable diseases surveillance: tables
Marburg haemorrhagic fever
overseas brief; 445–446
Measles
overseas brief; 258, 340
See also: Communicable diseases surveillance: tables
Meningococcal infection
annual report of the Australian Meningococcal Surveillance Programme, 2006; 185–194
overseas brief; 155, 258
public health management of increased incidence of meningococcal disease in the Australian Capital Territory: 2003 to 2004; 112–118
quarterly surveillance report; 162, 254, 336, 441
reduction in invasive meningococcal disease in Queensland: A success for immunisation; 227–232
septicaemia and a case of clinically mild illness; 232–233
See also: Communicable diseases surveillance: tables
Methicillin-resistant Staphylococcus aureus
overseas brief; 155
Mumps
overseas brief; 258
See also: Communicable diseases surveillance: tables
Murray Valley encephalitis virus
See: Communicable diseases surveillance: tables
Mycobacterium
See: Tuberculosis
Top of pageN
National Centre in HIV Epidemiology and Clinical Research
See: HIV and AIDS
National Enteric Pathogens Surveillance System
quarterly surveillance report; 151–153, 254–256, 337–338, 442–443
surveillance data in CDI explanation; 163
National Influenza Surveillance Scheme
annual report, 2006; 167–179
surveillance data in CDI explanation; 161
See also: Influenza
National Mycobacterial Surveillance Scheme
See: Tuberculosis
National Notifiable Diseases Surveillance System
annual report, 2005; 1–70
highlights for 4th quarter, 2006; 134–137
highlights for 1st quarter, 2007; 240–241
highlights for 2nd quarter, 2007; 319–320
highlights for 3rd quarter, 2007; 425–426
surveillance data in CDI explanation; 160
tables; 138–143, 242–247, 321–326, 427–432
National Serology Reference Laboratory, Australia, workshop; 261
National Tuberculosis Advisory Committee
multi-drug resistant tuberculosis: Information Paper (October 2007); 406–409
Position statement on interferon-g release immunoassays in the detection of latent tuberculosis infection, October 2007; 404–405
See also: Malaria
Neisseria gonorrhoeae
See: Gonococcal infection
Neisseria meningitdis
See: Meningococcal infection
Nipah virus
overseas brief; 340–341
Norwalk virus
See: Norovirus
Notifiable diseases
See: Communicable diseases surveillance;
See also: National Notifiable Diseases Surveillance System
Top of pageO
Ornithosis
See also: Communicable diseases surveillance: tables
Overseas briefs; 154–156, 257–259, 339–342, 444–447
OzFoodNet
annual report, 2006; 345–365
quarterly surveillance report
1 October to 31 December 2006; 128–133
1 January to 31 March 2007; 234–239
1 April to 30 June 2007; 314–318
1 July to 30 September 2007; 420–424
surveillance data in CDI explanation; 164
Top of pageP
Pandemic Influenza
Exercise Paton: A simulation exercise to test New South Wales emergency departments’ response to pandemic influenza; 310–313
Pertussis
Bordetella pertussis PCR positivity, following onset of illness in children under 5 years of age; 202–205
epidemiology in Australia over the decade 1995–2005 – trends by region and age group; 205–213
epidemiology of pertussis in the Australian Capital Territory, 1999 to 2005—epidemics of testing, disease or false positives?; 383–391
See also: Communicable diseases surveillance: tables
Plague
See also: Communicable diseases surveillance: tables
Plasmodium spp.
See: Malaria
Pneumococcal disease
annual report 2005; 86–100
See also: Communicable diseases surveillance: tables
Pneumonia cluster in a boarding school – implications for influenza control; 296–298
Poliomyelitis
Australian National Poliovirus Reference Laboratory
annual report, 2006; 263–269
importation of wild poliovirus into Australia, July 2007; 299
overseas brief; 155–156, 258–259, 341, 446
See also: Communicable diseases surveillance: tables
Professor Aileen Plant, a celebration of the life of; 260
Public health management of increased incidence of meningococcal disease in the Australian Capital Territory: 2003 to 2004; 112–118
Top of pageQ
Q fever
cases in the Northern Territory of Australia from 1991 to 2006; 222–227
See also: Communicable diseases surveillance: tables
Quarantinable diseases
See: Cholera; plague; rabies; smallpox; tularemia; viral haemorrhagic fever; yellow fever
See also: Communicable diseases surveillance: tables;
Top of pageR
Rabies
See: Communicable diseases surveillance: tables
Rift Valley fever
overseas brief; 156, 259
Ross River virus infection
See: Communicable diseases surveillance: tables
Rotavirus
annual report, 2006-07; 375–379
Rubella
See: Communicable diseases surveillance: tables
Top of pageS
Salmonella
See: Salmonellosis
Salmonellosis
large outbreaks of Salmonella Typhimurium phage type 135 infections associated with the consumption of products containing raw egg in Tasmania; 118–124
See also: Communicable diseases surveillance: tables
SARS
See: Severe acute respiratory syndrome
Sentinel Chicken Surveillance Program
surveillance data in CDI explanation; 161–162
Serology
See: Laboratory Virology and Serology Reporting Scheme
Sexually transmissible infections
See: Chlamydial infection; gonococcal infection; syphilis
See also: Communicable diseases surveillance: tables
Shigellosis
See: Communicable diseases surveillance: tables
SLTEC
See: Shiga-like toxin producing Escherichia coli/verotoxin producing E. coli
Smallpox
See: Communicable diseases surveillance: tables
Staphylococcus aureus
epidemiology and outcomes for Staphylococcus aureus bacteraemia in Australian hospitals, 2005–06; 398–404
overseas brief; 155
prevalence of MRSA among Staphylococcus aureus isolated from hospital inpatients, 2005: Report from the Australian Group for Antimicrobial Resistance; 288–296
Surveillance
adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2007; 379–382
report for active trachoma, 2006; 366–374
systems reported in CDI, 2007; 159–164
See: Communicable diseases surveillance
Surveillance reports
See: Communicable diseases surveillance
Syphilis
See: Communicable diseases surveillance: tables
in remote north Queensland; 125–127
Top of pageT
Tetanus
See: Communicable diseases surveillance: tables
Trachoma
surveillance report for active trachoma, 2006; 366–374
Transmissible spongiform encephalopathies
See: Creutzfeldt-Jakob disease
Tuberculosis
bacteriologically confirmed cases and drug resistance, annual report 2005; 80–86
National Tuberculosis Advisory Committee multi-drug resistant tuberculosis: Information Paper (October 2007); 406–409
notifications in Australia, annual report 2005; 71–80
overseas brief; 341–342
position statement on interferon-g release immunoassays in the detection of latent tuberculosis infection, October 2007; 404–405
See also: Communicable diseases surveillance: tables
Tularemia
See: Communicable diseases surveillance: tables
Typhoid
See: Communicable diseases surveillance: tables
Top of pageV
Vaccination
compliance with three simultaneous vaccinations due at the one visit at 12 months of age in Australia; 198–202
reduction in invasive meningococcal disease in Queensland: A success for immunisation;
227–232
See: Childhood immunisation coverage
Vaccine preventable diseases and Vaccination Coverage in Australia, 2003 to 2005 - supplement; S1–S152
See also: Communicable diseases surveillance: tables;
See also: Diphtheria; Haemophilus influenzae type b; influenza; measles; mumps; pertussis; pneumococcal disease; poliomyelitis; rubella; tetanus
Varicella
Current developments in varicella-zoster virus disease prevention; 303–310
Vectorborne diseases
See: Barmah Forest virus infection; dengue; flavivirus; Japanese encephalitis virus; Kunjin virus infection; malaria; Murray Valley encephalitis virus; Ross River virus infection
See also: Communicable diseases surveillance: tables;
Viral haemorrhagic fever
See: Communicable diseases surveillance: tables
Virology and Serology Laboratory Reporting Scheme
See: Laboratory Virology and Serology Reporting Scheme
VTEC
See: Shiga-like toxin producing Escherichia coli/verotoxin producing E. coli
Top of pageW
West Nile fever
overseas brief; 446
Y
Yellow fever
overseas brief; 156
See also: Communicable diseases surveillance: tables
Z
Zoonoses
See: Anthrax; Australian bat lyssavirus; brucellosis; leptospirosis; ornithosis; Q fever
See also: Communicable diseases surveillance: tables;